MAPT and Alzheimer disease: To make a case for the existence of Alzheimer’s disease in chimpanzees, validated cognitive tests for Alzheimer’s-like cognitive decline in non-human primates are needed, to test for direct associations between cognitive decline with tau pathology and brain atrophy.